You are here: Industry Insights > Sanofi

News List

US approves Sanofi's meningococcal vaccine pharmatimes
April 24, 2020
US regulators have issued a green light for Sanofi's meningococcal vaccine MenQuadfi for the prevention of invasive meningococcal disease in persons two years of age and older.
Sanofi to donate 100 million doses of hydroxychloroquine across 50 countries worldpharmanews
April 15, 2020
Sanofi has committed to donating 100 million doses of hydroxychloroquine to 50 countries around the world, and has begun to progressively deliver the medicine to authorities that have requested it.
Sanofi and GSK partner to develop Covid-19 vaccine pharmaceutical-technology
April 15, 2020
Sanofi and GlaxoSmithKline (GSK) have signed a letter of intent for a partnership focused on developing an adjuvanted vaccine for Covid-19.
Sanofi unveils new data for Dupixent in children with dermatitis pharmatimes
April 03, 2020
Sanofi has unveiled more detailed late-stage data showing the benefit of biologic Dupixent (dupilumab) in a population of young patients with uncontrolled severe atopic dermatitis.
First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 worldpharmanews
April 03, 2020
The first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara® (sarilumab) in patients hospitalized with severe COVID-19.
COVID-19: NICE updates guideline as Sanofi announces vaccine development pharmatimes
March 31, 2020
As the number of deaths in the UK more than doubled over the weekend, The National Institute for Health and Care Excellence (NICE) has updated its rapid COVID-19 critical care guideline.
Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease pharmaceutical-business-review
March 31, 2020
Sanofi’s vaccines global business unit Sanofi Pasteur has collaborated with Translate Bio for the development of a novel messenger RNA (mRNA) vaccine for COVID-19, the disease resulted due to the novel coronavirus SARS-CoV-2.
CHMP gives Sanofi positive opinion for Sarclisa pharmatimes
March 30, 2020
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Sarclisa (isatuximab).
Sanofi and Translate Bio to develop mRNA vaccine for Covid-19 pharmaceutical-technology
March 30, 2020
Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.
No scientific evidence to establish link between ibuprofen and worsening of Covid-19: Sanofi expresspharma
March 23, 2020
Pharma major Sanofi announced that there is currently no scientific evidence establishing a link between ibuprofen and worsening of COVID-19.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 43 44 Next page